Of course the ChatGPT dog cancer vaccine spawned a startup
The ChatGPT dog-cancer-vaccine story just became a startup. Meet Gamgee, and why this matters for AI-powered drug discovery.
Why it matters
A viral AI-for-medicine moment has materialized into a funded company targeting personalized mRNA cancer vaccines. It signals both the real commercial appetite for AI-assisted biotech AND the startup ecosystem's speed in capitalizing on AI breakthroughs — whether they'll scale is another question.
The key facts
4 to knowPaul Conyngham launched Gamgee after viral success using ChatGPT and Grok to design a personalized cancer vaccine for his dog Rosie
Gamgee targets personalized mRNA cancer vaccines, starting with dogs, with plans to expand to humans and other diseases
Company website positions AI and genetics as core to drug-discovery approach
Represents rapid commercialization of AI-for-biotech narrative; unclear if this is funded round or pre-revenue startup announcement
Go to the source
The Verge AItheverge.com
Publisher excerpt: Remember that much-hyped story about an Australian tech entrepreneur using ChatGPT, Grok, and other AI tools to craft a personalized cancer vaccine for his dog? Well, surprise: he's launched a startup. That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer "personalised mRNA…